Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Securities
Issues & Trends

PROTEINA CO., LTD. Partners with U.S.-Based Twist BioSciences to Validate AI-Driven New Drug Development

AI-driven new drug development company #PROTEINA CO., LTD. announced on the 27th that it has partnered with Twist Bioscience, a company listed on the U.S. Nasdaq, to collaborate on the development of …
  • 2026-08-27 09:08:30
  • Kim Hyung-il
Issues & Trends

Finemedix Co., Ltd. Participates in Korea-U.S. Joint R&D… Developing an Endoscope-Based Pancreatic Cancer Treatment Device

#Finemedix Co., Ltd., a gastrointestinal endoscopy solutions company, announced on the 27th that it has been selected as a joint research institution for the Ministry of Health and Welfare’s “2026 Res…
  • 2026-08-27 08:58:58
  • Kim Hyung-il
Issues & Trends

NGeneBio Co., Ltd. Signs MOU with Incheon Sejong Hospital to Develop Customized Testing for GLP-1 Obesity Treatment

AI precision medicine company NGeneBio Co., Ltd.(354200)announced on the 27th that it has signed a Memorandum of Understanding (MOU) with Incheon Sejong Hospital to jointly develop genetic and blood t…
  • 2026-08-27 08:51:57
  • Kim Hyung-il
Issues & Trends

VIVOZON PHARMACEUTICAL Signs Contract to Supply Finished Anaprazu Products to Hainan Special Medical Zone in China

VIVOZON PHARMACEUTICAL(082800)is accelerating its entry into the Chinese market with its non-narcotic analgesic “Anapraz.” VIVOZON PHARMACEUTICAL announced on the 27th that it has signed a contract wi…
  • 2026-08-27 08:49:10
  • Kwon Oh Seok
Issues & Trends

LINCSOLUTION CO., LTD. Sees Mass Production Expansion Take Shape with First Foundry Order—Shinhan

On the 26th, Shinhan Investment Securities stated that LINCSOLUTION CO., LTD. has confirmed the range of items capable of mass production via 3D printing by securing its first foundry order from a maj…
  • 2026-08-27 08:38:09
  • Park Jung-Soo
Issues & Trends

Is Morgan Stanley Stepping In to Buy KoreaLine at a Discount? … Betting on LNG Growth Potential

Global investment bank Morgan Stanley has become a major shareholder in KoreaLine(005880). The move is seen as a bet on the company’s growth potential stemming from additional orders for liquefied nat…
  • 2026-08-26 16:28:43
  • Park Jung-Soo
Issues & Trends

Cosmetics Stocks Thrive While Semiconductors Stumble… Third-Quarter Earnings Forecasts Also ‘Soar’

While semiconductor stocks have paused for a breather, cosmetics stocks are surging sharply. Since the start of this month, the stock prices of COSMAX, INC., KOLMAR KOREA, and SILICON 2 Co.,Ltd. have …
  • 2026-08-26 16:23:50
  • KIM YOON-JEONG
Issues & Trends

Once Trading at 250,000 Won, Stock Price Ends Up in the 10,000 Won Range Following Merger… What Are the Gains and Losses for SKIET Shareholders?

SK Innovation(096770)is set to merge with SK ie technology(361610)(SKIET)—which it spun off in 2019—for the first time in seven years, leaving some 330,000 minority shareholders to shoulder the burden…
  • 2026-08-26 15:59:08
  • Kim Hyung-il
Issues & Trends

ICH Co., Ltd. to Supply Materials for Humanoid Robots to Global Electric Vehicle Company

ICH Co., Ltd.(368600), a company specializing in advanced electronic materials, announced on the 26th that it has begun mass-producing and supplying high-performance polyurethane (PU) foam materials f…
  • 2026-08-26 15:59:07
  • Park Jung-Soo
Issues & Trends

Abandoning Their 'Last Line of Defense' Amid Delisting Crisis… Kumyang Shareholders in 'High Alert'

Shareholder anxiety is reaching a fever pitch as Kumyang(001570), which stands on the brink of delisting, has failed to submit even its semi-annual report ahead of the expiration of the grace period g…
  • 2026-08-26 15:24:17
  • Kwon Oh Seok
prev 31 32 33 34 35 36 37 38 39 40 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English